Chronic Lymphocytic Leukemia Excellence Forum

Chronic Lymphocytic Leukemia

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Videos

Dr Tedeschi Reviews Zanubrutinib Plus Venetoclax for Patients With CLL

02/11/2022

Alessandra Tedeschi, MD, reviews early results from arm D of the SEQUOIA trial on zanubrutinib in combination with venetoclax for patients with treatment-naïve CLL or SLL with del(17p) aberrations.

Alessandra Tedeschi, MD, reviews...

02/11/2022

Oncology

Videos

Dr Shadman Discusses Safety and Efficacy of Third Generation CD20 Targeted CAR-T for R/R B-NHL, CLL

01/10/2022

Mayzar Shadman, MD, MPH, discusses the safety and efficacy of a third-generation CD20-targeted CAR-T therapy for relapsed/refractory B-NHL and CLL, presented at ASH 2021.

Mayzar Shadman, MD, MPH,...

01/10/2022

Oncology

Videos

James Dean, MD, PhD, Shares MRD Outcomes of Ibrutinib Plus Venetoclax for First-Line Treatment of CLL

01/04/2022

Dr Dean discusses minimal residual disease outcomes after fixed-duration ibrutinib plus venetoclax versus chlorambucil plus obinutuzumab for first-line treatment of CLL.

Dr Dean discusses minimal...

01/04/2022

Oncology

Videos

Ibrutinib Plus Venetoclax Yields Deep Responses in Patients With CLL

12/16/2021

Paolo Ghia, MD, PhD, discusses 2-year follow-up results from the phase 2 CAPTIVATE study on first-line ibrutinib plus venetoclax for the treatment of patients with CLL. These data were presented at the 2021 ASH Annual Meeting.

Paolo Ghia, MD, PhD, discusses...

12/16/2021

Oncology

Videos

Live CLL Cells Inside Bone Marrow Fibroblasts May Have Implication in Drug Resistance

11/29/2021

Lynn Wang, MD, PhD, FCAP, discusses live CLL cells inside the bone marrow fibroblasts and their implication in drug resistance. These data were presented at the 2021 LL&M Congress.

Lynn Wang, MD, PhD, FCAP,...

11/29/2021

Oncology

Videos

Dr Cheson Discusses Anti-CD20 Monoclonal Antibodies in Patients With CLL

11/23/2021

Bruce Cheson, MD, FACP, FAAAS, FASCO, discusses anti-CD20 monoclonal antibodies for the management of patients with CLL; these data were presented at the virtual LL&M Congress.

Bruce Cheson, MD, FACP, FAAAS,...

11/23/2021

Oncology

Videos

Javier Pinilla, MD, PhD, Highlights MRD in Patient Care for a Variety of Blood Cancers

11/16/2021

Javier Pinilla, MD, PhD, discusses the importance of MRD in patient care as well as its significance as an endpoint in clinical trials for new immunotherapies to treat a variety of blood cancers, including CLL.

Javier Pinilla, MD, PhD,...

11/16/2021

Oncology

Videos

Dr Kittai Highlights the Patient Perspective for CLL

10/25/2021

Adam Kittai, MD, discusses the perspectives of patients getting treatment or diagnosis in CLL.

Adam Kittai, MD, discusses the...

10/25/2021

Oncology

Interview

Dr Choi Discusses How To Best Sequence Regimens for Patients With CLL

10/25/2021

Michael Choi, MD, discusses how to best sequence regimens in the management of patients with CLL. This data was presented at the virtual 2021 LL&M Congress.

Michael Choi, MD, discusses how...

10/25/2021

Oncology

Interview

Dr Danilov Talks Clonal Dynamics and Venetoclax Resistance in CLL

10/22/2021

Alexey Danilov, MD, PhD, discusses clonal dynamics from the phase 3 CLL14 trial and mechanisms of resistance with venetoclax in patients with CLL at the 2021 virtual LL&M Congress.

Alexey Danilov, MD, PhD,...

10/22/2021

Oncology

Chronic Lymphocytic Leukemia Excellence Forum

Specialties

Events

Year Round Education

HMP Global Products